Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 14, 2025 08:00 ET | Source: CYTOMED THERAPEUTICS LIMITED

CytoMed makes cash bid for potential acquisition of TC BioPharm Limited’s relevant assets

SINGAPORE, Oct. 14, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing...
October 08, 2025 07:09 ET | Source: Nilo Therapeutics

Nilo Therapeutics launches with $101 million Series A financing to advance a new class of medicines targeting neural circuits in immune disease and appoints Kim Seth as Chief Executive Officer

Nilo Therapeutics launches with $101 million Series A to target neural circuits in immune disease and appoints Kim Seth as Chief Executive Officer
October 07, 2025 10:30 ET | Source: Precedence Research

Digital Therapeutics Market Size to Lead USD 56.76 Bn by 2034 Driven by Digital Therapeutics, Cost Control, and Chronic Disease Prevalence

Ottawa, Oct. 07, 2025 (GLOBE NEWSWIRE) -- According to Statifacts, the global digital therapeutics market size reached USD 7.88 billion in 2024 and is estimated to attain USD 56.76 billion by 2034,...
September 16, 2025 13:00 ET | Source: UTR Therapeutics Inc.

UTR Therapeutics Publishes Landmark Preclinical Data in Frontiers in Pharmacology Supporting IND Submission for First-in-Class c-MYC RNA Therapeutic

UTR Therapeutics Inc Publishes Data supporting US FDA IND for a First-in-Human Clinical Trial of mRNA destabilizing drug targeting c-MYC driven cancer
September 04, 2025 11:00 ET | Source: Precedence Research

Monoclonal Antibodies Therapeutics Market Size Projected to Reach USD 1,057.91 Billion by 2034

Ottawa, Sept. 04, 2025 (GLOBE NEWSWIRE) -- The global monoclonal antibody therapeutics market size was estimated at USD 265.17 billion in 2024 and is projected to reach approximately USD 1,057.91...
September 04, 2025 07:30 ET | Source: A Race Against Blindness

A Race Against Blindness Awards Additional $1 Million Grant to Advance Clinical Trial for Sight-Saving Gene Therapy for Bardet-Biedl Syndrome 1 (BBS1)

PHOENIX, Sept. 04, 2025 (GLOBE NEWSWIRE) -- A Race Against Blindness, the Arizona-based 501(c)(3) nonprofit founded by Dr. Stephen Johnston and Kristina Johnston, announced today that it has awarded...
September 03, 2025 09:00 ET | Source: Persephoni BioPartners

Persephoni Launches Strategic Sponsorship with American Cancer Society’s BrightEdge to Accelerate Oncology Innovation

RESEARCH TRIANGLE PARK, N.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Persephoni BioSciences LLC ("Persephoni"), a leading global life sciences venture studio, is proud to announce a $1.5 million...
August 28, 2025 10:00 ET | Source: CMI

Vitamin D Therapy Market Poised for Explosive Growth, Projected to Hit USD 5.62 Billion by 2032 | Coherent Market Insights

Burlingame, CA, Aug. 28, 2025 (GLOBE NEWSWIRE) -- The Global Vitamin D Therapy Market is estimated to be valued at USD 2.64 Bn in 2025 and is expected to reach USD 5.62 Bn by 2032, exhibiting a...
August 12, 2025 22:30 ET | Source: Custom Market Insights

[Latest] US Personalized Medicine Market Size/Share Worth USD 252.93 Billion by 2034 at a 17.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “US Personalized Medicine Market Size, Trends and Insights By Product...
June 23, 2025 02:30 ET | Source: Enterome

Enterome presents positive Phase 2 interim results in relapsed/refractory indolent non-Hodgkin lymphoma after EO2463 OncoMimics™ immunotherapy treatment at ICML

60% (12/20) complete response rate after treatment with EO2463 in combination with lenalidomide and rituximab (R2) EO2463 plus R2 was well tolerated in patients with follicular and marginal zone...